Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac
Author Information
Author(s): Asare Eric, Emmanuel Shalom, Du Ting, Xie Huan, Liang Dong, Gao Song
Primary Institution: Texas Southern University
Hypothesis
The study aims to determine the impact of species and tissue differences on the glucuronidation of diclofenac in vitro.
Conclusion
The liver is the major organ for the glucuronidation of diclofenac, and this process varies significantly across different species.
Supporting Evidence
- The liver showed higher rates of diclofenac metabolism compared to the intestine and kidney.
- Mouse liver microsomes had the highest maximum reaction rate for diclofenac glucuronidation.
- UGT2B7 was identified as the major isoform responsible for diclofenac glucuronidation.
Takeaway
This study found that the liver helps break down diclofenac, a common pain medicine, and that different animals process it differently.
Methodology
The study used microsomes from various species and tissues to assess the glucuronidation rates of diclofenac, analyzed via ultra high-performance liquid chromatography.
Limitations
The study only involved in vitro methods and did not assess sex-dependent differences in glucuronidation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website